{"id":458939,"date":"2021-03-16T12:03:08","date_gmt":"2021-03-16T16:03:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458939"},"modified":"2021-03-16T12:03:08","modified_gmt":"2021-03-16T16:03:08","slug":"nabp-reaffirms-support-for-covid-19-vaccines","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/","title":{"rendered":"NABP Reaffirms Support for COVID-19 Vaccines"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MOUNT PROSPECT, IL, March  16, 2021  (GLOBE NEWSWIRE) &#8212; The National Association of Boards of Pharmacy<sup>\u00ae<\/sup>\u00a0(NABP<sup>\u00ae<\/sup>) proudly announces its continued confidence in the safety of the coronavirus disease 2019 (COVID-19) vaccines approved for emergency use authorization by Food and Drug Administration. The authorized vaccines have followed a strict testing and approval process throughout all stages of vaccine development. \u201cWe can have greater control over the spread of this virus by getting vaccinated and encouraging patients to get vaccinated,\u201d says NABP Executive Director Lemrey \u201cAl\u201d Carter, PharmD, MS, RPh. \u201cWearing masks, social distancing, and washing hands can be effective, but the vaccines have shown to be an important next step to gaining control of the virus.\u201d <\/p>\n<p>In addition, vaccinated patients can return to some everyday activities at low risk to themselves, according to the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rel5jxqmw1F6VF131PK4wZl6baG376n4fvD6_xMG7-9Ei0j64OdhbjoRiXEPpw8730J6HFOihhV-butvB4zIBwBgSK-Hx1eSf1xOIBYAIkjM8nyn1B3fF0c5OeTYW1Yq2um6hYFWh8xlyb8cDscLGCMLGrmjQlL8LFjkMCHriCNpZQzmEVrw0QwvedGe95_PjmLtZhV56CkbGLh4N22U2g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>latest Centers for Disease Control and Prevention research<\/u><\/a>. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=297YjB2mq2svsdh1WTRnRq4SvDnsL3pVTwG76ghQ76d6KLuVTmpyoIS5azTmpzI1shmNO-w76qW7-IA05LBTTlYVX1aO8i8RV8sX6q6QPevpemP8wYWjBXYVCqUfUEeFWlk6_zg8RuCCHchjrJuN8Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Evidence shows<\/u><\/a> that fully vaccinated people are less likely to have asymptomatic infection and potentially less likely to transmit the virus to others. <\/p>\n<p>Nearly <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wMrWZaB1TwWpZr0GxCjJWbawTR6e1mSku-Wh_nyB5tLqGMNcET_HclMRlZQFxqKWRPE691gB2zaM54qFl5DDk0eBo8xA8IjWi0h1ggZhKwIBv3qQlAdnK39Wk-X9F7wH\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>38.5 million people<\/u><\/a>, or 11.5% of the total population, have been fully vaccinated in the United States at the time of this release, but part of the US population has expressed concern about the safety of the vaccine and is hesitant to receive it. As we work toward higher vaccination numbers, the role pharmacists can play to educate patients about the COVID-19 vaccine is even greater. These accessible, frontline health care providers have an opportunity to advance patients\u2019 knowledge and understanding of the vaccines\u2019 safety and efficacy by demonstrating their own confidence in the vaccine. <\/p>\n<p>NABP supports its member boards of pharmacy in their quest for efficient and equitable distribution of the COVID-19 vaccines. The boards determinedly work with local, state, and federal agencies to increase the public\u2019s access to the vaccine and facilitate pharmacists\u2019 and pharmacy technicians\u2019 ability to safely administer the COVID-19 vaccine. <\/p>\n<p>\u201cIt is inspiring to see the increased collaboration between our profession and other agencies to support the public\u2019s health and safety during these difficult times,\u201d notes Carter.<\/p>\n<p>To further increase the education surrounding the COVID-19 vaccine, NABP has shared a number of resources that provide board of pharmacy members and staff, practicing pharmacists and pharmacy technicians, and consumers with vaccine facts and updates. Resources for health care providers can be found on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tgmciiTOMi8XtKwIBvvm4sm835gnOy6F0JDYZWQdrZqLf4vKeY3-_eEbtqGBIe_Ydgr2SUPnm4-jH8BkHLo0aXX5CEnH0FYgmGkdGuZYd2H2isG2WdnjKbkT8gpX3S4jYw96kEpRwResVfo4m83ASQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>NABP website<\/u><\/a>, and information geared toward patients\u2019 education can be found on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AApYhU7yu8yU0CkeBAzKyToJNFEADRwZUqUhLIm4tONofArS3BPJsTXznIUJWYETVFYt8jGTmM-0FK6-6SB8iNklTU-B5suFtq0Bd184otXWLBE--lAOxAIUO_KbfsSp\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>NABP\u2019s consumer website<\/u><\/a>.<\/p>\n<p>\n        <em><br \/>\n          <br \/>\n        <\/em>\n      <\/p>\n<p>\n        <em>NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.<\/em>\n      <\/p>\n<p align=\"center\">&#8211; 30 &#8211;<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f1646ca3-dc51-41a6-8655-9f0b79a1edb8\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Larissa Doucette\r\n847\/391-4405\r\nhelp@nabp.pharmacy<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MOUNT PROSPECT, IL, March 16, 2021 (GLOBE NEWSWIRE) &#8212; The National Association of Boards of Pharmacy\u00ae\u00a0(NABP\u00ae) proudly announces its continued confidence in the safety of the coronavirus disease 2019 (COVID-19) vaccines approved for emergency use authorization by Food and Drug Administration. The authorized vaccines have followed a strict testing and approval process throughout all stages of vaccine development. \u201cWe can have greater control over the spread of this virus by getting vaccinated and encouraging patients to get vaccinated,\u201d says NABP Executive Director Lemrey \u201cAl\u201d Carter, PharmD, MS, RPh. \u201cWearing masks, social distancing, and washing hands can be effective, but the vaccines have shown to be an important next step to gaining control of the virus.\u201d In addition, vaccinated patients can &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NABP Reaffirms Support for COVID-19 Vaccines&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458939","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NABP Reaffirms Support for COVID-19 Vaccines - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NABP Reaffirms Support for COVID-19 Vaccines - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MOUNT PROSPECT, IL, March 16, 2021 (GLOBE NEWSWIRE) &#8212; The National Association of Boards of Pharmacy\u00ae\u00a0(NABP\u00ae) proudly announces its continued confidence in the safety of the coronavirus disease 2019 (COVID-19) vaccines approved for emergency use authorization by Food and Drug Administration. The authorized vaccines have followed a strict testing and approval process throughout all stages of vaccine development. \u201cWe can have greater control over the spread of this virus by getting vaccinated and encouraging patients to get vaccinated,\u201d says NABP Executive Director Lemrey \u201cAl\u201d Carter, PharmD, MS, RPh. \u201cWearing masks, social distancing, and washing hands can be effective, but the vaccines have shown to be an important next step to gaining control of the virus.\u201d In addition, vaccinated patients can &hellip; Continue reading &quot;NABP Reaffirms Support for COVID-19 Vaccines&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T16:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NABP Reaffirms Support for COVID-19 Vaccines\",\"datePublished\":\"2021-03-16T16:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/\"},\"wordCount\":428,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/\",\"name\":\"NABP Reaffirms Support for COVID-19 Vaccines - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=\",\"datePublished\":\"2021-03-16T16:03:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nabp-reaffirms-support-for-covid-19-vaccines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NABP Reaffirms Support for COVID-19 Vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NABP Reaffirms Support for COVID-19 Vaccines - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/","og_locale":"en_US","og_type":"article","og_title":"NABP Reaffirms Support for COVID-19 Vaccines - Market Newsdesk","og_description":"MOUNT PROSPECT, IL, March 16, 2021 (GLOBE NEWSWIRE) &#8212; The National Association of Boards of Pharmacy\u00ae\u00a0(NABP\u00ae) proudly announces its continued confidence in the safety of the coronavirus disease 2019 (COVID-19) vaccines approved for emergency use authorization by Food and Drug Administration. The authorized vaccines have followed a strict testing and approval process throughout all stages of vaccine development. \u201cWe can have greater control over the spread of this virus by getting vaccinated and encouraging patients to get vaccinated,\u201d says NABP Executive Director Lemrey \u201cAl\u201d Carter, PharmD, MS, RPh. \u201cWearing masks, social distancing, and washing hands can be effective, but the vaccines have shown to be an important next step to gaining control of the virus.\u201d In addition, vaccinated patients can &hellip; Continue reading \"NABP Reaffirms Support for COVID-19 Vaccines\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T16:03:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NABP Reaffirms Support for COVID-19 Vaccines","datePublished":"2021-03-16T16:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/"},"wordCount":428,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/","name":"NABP Reaffirms Support for COVID-19 Vaccines - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=","datePublished":"2021-03-16T16:03:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MTA0OSM0MDY2OTUzIzIxODA3NTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nabp-reaffirms-support-for-covid-19-vaccines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NABP Reaffirms Support for COVID-19 Vaccines"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458939"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458939\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}